Key result
Only ~13% of pediatric patients with hypertrophic cardiomyopathy meet recommended daily step goals.
Why the study?
Pediatric HCM patients are advised to avoid strenuous exercise, leading to reduced physical activity and increased cardiovascular risk, but objective and subjective PA levels are not well characterized.
Cross-Sectional (n=56)
Yes
Answers are grounded in this paper and cite their sources.
Pediatric patients with hypertrophic cardiomyopathy engage in very low levels of physical activity, highlighting the need for safe, evidence-based exercise guidelines to mitigate long-term cardiovascular risk.
Background Pediatric hypertrophic cardiomyopathy (HCM) can increase risk of sudden cardiac death during physical activity (PA). As a result, patients are advised to avoid strenuous exercise, leading to reduced PA levels and increased body mass index, raising concerns for long-term cardiovascular health in this population. Our objective was to assess PA levels in children with HCM using subjective and objective reporting measures. Factors and/or barriers influencing physical activity levels were also evaluated. Methods 56 participants with HCM (10–19 years) were recruited from 10 pedatric cardiac centers between May 2019 and January 2023. PA was assessed using a Fitbit activity tracker for 14 days and two-self reported questionnaires: Healthy Heart School Program questionnaire and Habitual Activity Estimation Scale (HAES). The Self-Efficacy for Exercise Scale (SEE) evaluated factors influencing activity. Spearman correlation assessed relationships between Fitbit and HAES data. Results Of the 56 participants (71% male, median age 15.5 years), only 12.5% met the recommended daily step count of >12,500 and 4% reported 20 minutes of moderate-to-vigorous PA 7 days a week. Fitbit average daily steps positively correlated with HAES activity levels, although was not statistically significant. Perceived barriers to activity included pain and fatigue. Conclusions Pediatric participants with HCM engage in low PA, possibly due to exercise restrictions and perceived barriers. This raises concerns for long-term cardiovascular disease, highlighting the need for safe, evidence-based exercise guidelines in this population.
No takes yet. Share an insight, caveat, or question.
Srbely et al. (2026) conducted a cross-sectional in Hypertrophic cardiomyopathy (n=56). Hypertrophic cardiomyopathy was evaluated on Meeting the recommended daily step count of >12,500. Pediatric patients with hypertrophic cardiomyopathy exhibited low physical activity levels, with only 12.5% meeting the recommended daily step count of >12,500.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: